FGF23 and chronic kidney disease: All our patients had moderate (stage 3) chronic kidney disease and A2 albuminuria which is typically associated with increased levels of phosphaturic hormone at baseline and in particular, FGF-23, for which rise is usually seen ahead of the increase of serum PTH and phosphate, and the decrease of 1.25 (OH)2D [1].